Guidance Point Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$432K Buy
2,022
+4
+0.2% +$894 0.1% 65
2025
Q4
$345K Buy
2,018
+4
+0.2% +$622 0.08% 71
2025
Q3
$270K Buy
+2,014
New +$213K 0.07% 78
2024
Q3
Sell
-2,090
Closed -$223K 88
2024
Q2
$223K Sell
2,090
-10
-0.5% -$959 0.07% 74
2024
Q1
$205K Buy
+2,100
New +$185K 0.07% 82
2023
Q4
Sell
-4,150
Closed -$260K 72
2023
Q3
$260K Buy
4,150
+90
+2% +$5.91K 0.11% 62
2023
Q2
$261K Sell
4,060
-390
-9% -$22K 0.1% 66
2023
Q1
$236K Buy
+4,450
New +$218K 0.1% 70
2022
Q2
Sell
-4,390
Closed -$236K 91
2022
Q1
$236K Buy
4,390
+30
+0.7% +$1.75K 0.09% 83
2021
Q4
$314K Buy
4,360
+10
+0.2% +$627 0.11% 65
2021
Q3
$248K Buy
4,350
+10
+0.2% +$608 0.09% 78
2021
Q2
$282K Hold
4,340
0.11% 72
2021
Q1
$258K Hold
4,340
0.11% 76
2020
Q4
$204K Buy
+4,340
New +$183K 0.09% 80

Other funds holding LRCX

Guidance Point Advisors's LRCX Position: Q1 2026 in Review

Guidance Point Advisors increased its Lam Research (LRCX) stake by 0.2% in Q1 2026, buying an estimated $894 and bringing the position to 2,022 shares worth $432K. The position accounts for 0.1% of the portfolio, ranked #65.

Guidance Point Advisors first reported a position in LRCX in Q4 2020 and has held it in 14 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Guidance Point Advisors held 2,022 shares of Lam Research worth $432K as of Q1 2026.
  • Guidance Point Advisors bought 4 Lam Research shares in Q1 2026, an estimated $894.
  • Lam Research made up 0.1% of Guidance Point Advisors's portfolio in Q1 2026, its #65 holding.
  • Guidance Point Advisors first reported a position in Lam Research in Q4 2020 and has held it in 14 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Guidance Point Advisors's 13F filing for Q1 2026, filed 12 May 2026.